n(1)-methylnicotinamide has been researched along with Obesity in 5 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Excerpt | Relevance | Reference |
---|---|---|
"Patients with manifest type 2 diabetes have a significantly (approximately twofold) higher NNMT expression both in omental and subcutaneous WAT compared with controls." | 2.80 | Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance. ( Blüher, M; Dietrich, A; Kannt, A; Klöting, N; Pfenninger, A; Schön, MR; Teichert, L; Tönjes, A, 2015) |
"Obesity is a major health problem, and although caloric restriction and exercise are successful strategies to lose adipose tissue in obese individuals, a simultaneous decrease in skeletal muscle mass, negatively effects metabolism and muscle function." | 1.48 | N ( Ahlqvist, E; Almgren, P; Calbet, JAL; de Pablos-Velasco, P; Edlund, A; Ekman, C; Ekström, O; Eliasson, L; Fernandez, C; Groop, L; Hansson, O; Hjort, L; Holmberg, HC; Jörgensen, SW; Martin-Rincon, M; Mattiasson, M; Morales-Alamo, D; Oskolkov, N; Ottosson, F; Pérez-López, A; Perez-Suarez, I; Stenkula, KG; Ström, K; Vaag, A; Wierup, N; Zhou, Y, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, J | 1 |
Chen, Y | 1 |
Liu, C | 1 |
Li, L | 2 |
Li, P | 1 |
Ström, K | 1 |
Morales-Alamo, D | 1 |
Ottosson, F | 1 |
Edlund, A | 1 |
Hjort, L | 1 |
Jörgensen, SW | 1 |
Almgren, P | 1 |
Zhou, Y | 1 |
Martin-Rincon, M | 1 |
Ekman, C | 1 |
Pérez-López, A | 1 |
Ekström, O | 1 |
Perez-Suarez, I | 1 |
Mattiasson, M | 1 |
de Pablos-Velasco, P | 1 |
Oskolkov, N | 1 |
Ahlqvist, E | 1 |
Wierup, N | 1 |
Eliasson, L | 1 |
Vaag, A | 1 |
Groop, L | 1 |
Stenkula, KG | 1 |
Fernandez, C | 1 |
Calbet, JAL | 1 |
Holmberg, HC | 1 |
Hansson, O | 1 |
Kannt, A | 1 |
Pfenninger, A | 1 |
Teichert, L | 1 |
Tönjes, A | 1 |
Dietrich, A | 1 |
Schön, MR | 1 |
Klöting, N | 1 |
Blüher, M | 1 |
Liu, M | 2 |
Chu, J | 2 |
Zhu, B | 1 |
Zhang, Q | 1 |
Yin, X | 1 |
Jiang, W | 1 |
Dai, G | 1 |
Ju, W | 2 |
Wang, Z | 2 |
Yang, Q | 1 |
Fang, Z | 1 |
Gu, Y | 1 |
Shi, H | 1 |
Zhang, R | 1 |
Wang, L | 1 |
Chen, J | 1 |
Shen, L | 1 |
Yu, P | 1 |
Chen, X | 1 |
1 trial available for n(1)-methylnicotinamide and Obesity
Article | Year |
---|---|
Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance.
Topics: Adult; Aged; Bariatric Surgery; Biomarkers; Case-Control Studies; Cross-Sectional Studies; Diabetes | 2015 |
4 other studies available for n(1)-methylnicotinamide and Obesity
Article | Year |
---|---|
N
Topics: Acetylation; Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Type 2; Forkhead Box Protein O1; | 2020 |
N
Topics: Adult; Body Mass Index; Caloric Restriction; Cells, Cultured; Energy Metabolism; Exercise; Exercise | 2018 |
Serum N(1)-Methylnicotinamide Is Associated With Obesity and Diabetes in Chinese.
Topics: Adult; Asian People; Body Mass Index; China; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fem | 2015 |
Serum N1-Methylnicotinamide is Associated With Coronary Artery Disease in Chinese Patients.
Topics: Aged; Biomarkers; Body Mass Index; China; Chromatography, Liquid; Comorbidity; Coronary Angiography; | 2017 |